Skip to main content
SpringerLink
Log in

Inhaled Nitric Oxide Therapy

  • Chapter
ARDS Acute Respiratory Distress in Adults

  • 85 Accesses

Abstract

Since the first description of the syndrome of acute respiratory distress in adults (ARDS) in 1967 [1], there has been considerable debate concerning its exact definition. Specifically, distinguishing the syndrome from acute lung injury (ALI) has only recently been addressed. The relevance of the pulmonary hypertension that complicates ARDS and its role in the pathophysiology of the accompanying acute respiratory failure has also been the subject of investigation. ARDS has been defined recently as noncardiogenic pulmonary edema with refractory hypoxemia (Pao2 / FIO2 ratio < 27 kPa), associated with bilateral infiltrates on chest radiography [2].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ashbaugh, D.G., Bigelow, D.B., Petty, T.L. and Levine, B.E. (1967) Acute respiratory distress in adults. Lancet, ii, 319–23.

    Article  Google Scholar 

  2. Bernard, G.R., Artigas, A., Brigham, K.L. et al. (1994) Report of the American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes and clinical trial coordination. Intensive Care Med., 20, 225–32.

    Article  PubMed  CAS  Google Scholar 

  3. Zapol, W.M. and Snider, M.T. (1977) Pulmonary hypertension in severe acute respiratory failure. N. Engl. J. Med., 296, 476–80.

    Article  PubMed  CAS  Google Scholar 

  4. Villar, J., Blazquez, M.A., Lubillo, S. et al. (1989) Pulmonary hypertension in acute respiratory failure. Crit. Care Med., 17, 523–6.

    Article  PubMed  CAS  Google Scholar 

  5. Radermacher, P., Huet, Y., Pluskwa, F. et al. (1988) Comparison of ketanserin and sodium nitroprusside in patients with severe ARDS. Anesthesiology, 68, 152–7.

    Article  PubMed  CAS  Google Scholar 

  6. Bone, R.C., Slotman, G., Maunder, R.J. et al. (1989) Randomized double-blind, multicenter study of prostaglandin El in patients with the adult respiratory distress syndrome. Chest, 96, 114–9.

    Article  PubMed  CAS  Google Scholar 

  7. Morgan, J.M., McCormack, D.G., Griffiths, M.J.D. et al. (1991) Adenosine as a vasodilator in primary pulmonary hypertension. Circulation, 84, 1145–9.

    Article  PubMed  CAS  Google Scholar 

  8. Radermacher, P., Santak, B., Wust, H.J. et al. (1990) Prostacyclin for the treatment of pulmonary hypertension in the adult respiratory distress syndrome: effects on pulmonary capillary pressure and ventilation-perfusion distributions. Anesthesiology, 72, 238–444.

    Article  PubMed  CAS  Google Scholar 

  9. Palmer, R.M.J., Ferrige, A.G., and Moncada, S. (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature, 327, 524–6.

    Article  PubMed  CAS  Google Scholar 

  10. Davy, H. (1800) Researches, Chemical and Philosophical; Chiefly Concerning Nitrous Oxide, or Dephllogisticated Nitrous Air, and its Respiration, J. Johnson, London.

    Google Scholar 

  11. Clutton-Brock, J. (1967) Two cases of poisoning by contamination of nitrous oxide with higher oxides of nitrogen during anaesthesia. Br. J. Anaesth., 39, 388–92.

    Article  PubMed  CAS  Google Scholar 

  12. Health and Safety Executive (1991) EH40/91 Occupational Exposure Limits for use with the Control of Substances Hazardous to Health Regulations 1988, HMSO, London, pp 21.

    Google Scholar 

  13. Scott, E.G. and Hunt, W.B. Jr (1973) Silo filler’s disease. Chest, 63, 701–6.

    Article  PubMed  CAS  Google Scholar 

  14. Norman, V., and Keith, C.H. (1965) Nitrogen oxides in tobacco smoke. Nature, 205, 915–6.

    Article  CAS  Google Scholar 

  15. Higenbottam, T.W., and Borland, C. (1987) NO yields of contemporary UK, US and French cigarettes. Int. J. Epidemiol, 16, 31–4.

    Article  PubMed  Google Scholar 

  16. Furchgott, R.F. and Zawadzki, J.V. (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature, 288, 373–6.

    Article  PubMed  CAS  Google Scholar 

  17. Stamler, J.S., Jaraki, O., Osborne, J. et al. (1992) Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc. Natl Acad. Sei USA, 89, 7674–7.

    Article  CAS  Google Scholar 

  18. Moncada, S., Palmer, R.M.J, and Higgs, E.A. (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev., 43, 109–42.

    PubMed  CAS  Google Scholar 

  19. Palmer, R.M.J., Ashton, D.S. and Moncada, S. (1988) Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature, 333, 664–6.

    Article  PubMed  CAS  Google Scholar 

  20. Bredt, D.S., Hwang, P.M., Glatt, C.E. et al (1991) Cloned and expressed nitric oxide synthase structurally resembles cytochrome P450 reductase. Nature, 351, 714–8.

    Article  PubMed  CAS  Google Scholar 

  21. Radomski, M.W., Palmer, R.M.J., and Moncada, S. (1990) Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc. Natl Acad. Sei. USA, 87, 10043–7.

    Article  CAS  Google Scholar 

  22. Rees, D.D., Palmer, R.M.J, and Moncada, S. (1989) Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc. Natl Acad. Sei USA, 86, 3375–8.

    Article  CAS  Google Scholar 

  23. Rand, M.J. (1992) Nitrergic transmission: nitric oxide as a mediator of non-adrenergic, non-cholinergic neuroeffector transmission. Clin. Exp. Pharmacol. Physiol, 19, 147–69.

    Article  PubMed  CAS  Google Scholar 

  24. Rajfer, J., Aronson, W.J., Bush, P.A. et al. (1992) Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrener-gic, noncholinergic neurotransmission. N. Engl J. Med., 326, 90–4.

    Article  PubMed  CAS  Google Scholar 

  25. Desai, K.M., Zembowicz, A., Sessa, W.C. and Vane, J.R. (1991) Nitroxergic nerves mediate vagally induced relaxation in the isolated stomach of the guinea pig. Proc. Natl Acad. Sei. USA, 88, 11490–4.

    Article  CAS  Google Scholar 

  26. Belvisi, M.G., Stretton, C.D. and Barnes, P.J. (1992) Nitric oxide is the endogenous neurotransmitter of bronchodilator nerves in human airways. Eur. J. Pharmacol, 210, 221–2.

    Article  PubMed  CAS  Google Scholar 

  27. Sanders, K. (1992) Nitric oxide and the nervous system. Lancet, 339, 50–1.

    Article  Google Scholar 

  28. Garthwaite, J. (1993) Nitric oxide signalling in the nervous system. Neuroscience, 5, 171–80.

    CAS  Google Scholar 

  29. Knowles, R.G., Merrett, M., Salter, M. and Moncada, S. (1990) Differential induction of brain, lung and liver nitric oxide synthase by endotoxin in the rat. Biochem. J., 270, 833–6.

    PubMed  CAS  Google Scholar 

  30. Nathan, C. and Hibbs, J.B. Jr (1991) Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr. Opin. Immunol, 3, 65–70.

    Article  PubMed  CAS  Google Scholar 

  31. Hibbs, J.B. Jr (1992) Overview of cytotoxic mechanisms and defence of the intracellular environment against microbes, in The Biology of Nitric Oxide, Part 2 (eds S. Moncada, M.A. Marietta, J.B. Bibbs Jr and E.A. Higgs), Portland Press, London, pp. 201–6.

    Google Scholar 

  32. Rees, D.D., Cellek, S., Palmer, R.M.J, and Moncada, S. (1990) Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: an insight into endotoxin shock. Biomed. Biophys. Res. Commun., 173, 541–7.

    Article  CAS  Google Scholar 

  33. Kilbourn, R.G., Jubran, A., Gross, S.S. et al (1990) Reversal of endotoxin-mediated shock by N-methyl-L-arginine, an inhibitor of nitric oxide synthesis. Biomed. Biophys. Res. Commun., 172, 1132–8.

    Article  CAS  Google Scholar 

  34. Kolb, H. and Kolb-Bachofen, V. (1992) Nitric oxide, a pathogenetic factor in autoimmunity. Immunol. Today, 13, 157–60.

    Article  PubMed  CAS  Google Scholar 

  35. McCartney, F.N., Allen, J.B., Mizel, D.E. et al. (1993) Suppression of arthritis by an inhibitor of nitric oxide synthase. J. Exp. Med., 178, 749–54.

    Article  Google Scholar 

  36. McVeigh, G.E., Brennan, G.M. and Johnston, G.D. (1992) Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin dependent) diabetes mellitus. Diabetologia, 35, 771–6.

    PubMed  CAS  Google Scholar 

  37. Middleton, S.J., Shorthouse, M. and Hunter, J.O. (1993) Increased nitric oxide synthesis in ulcerative colitis. Lancet, 341, 465–6.

    Article  PubMed  CAS  Google Scholar 

  38. Borland, C.D.R. and Higenbottam, T.W. (1989) A simultaneous single breath measurement of pulmonary diffusing capacity with nitric oxide and carbon monoxide. Eur. Respir. J., 2, 56–63.

    PubMed  CAS  Google Scholar 

  39. Pepke-Zaba, J., Higenbottam, T.W., Dinh-Xuan, A.T. et al. (1991) Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet, 338, 1173–4.

    Article  PubMed  CAS  Google Scholar 

  40. Snow, D.J., Gray, S.J., Foubert, L. et al. (1994) Inhaled nitric oxide in patients with normal and increased pulmonary vascular resistance after cardiac surgery. Br. J. Anaesth., 72, 185–9.

    Article  PubMed  CAS  Google Scholar 

  41. Frostell, C., Fratacci, M.D., Wain, J.C et al (1991) Inhaled nitric oxide — a selective vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation, 83, 2038–47.

    Article  PubMed  CAS  Google Scholar 

  42. Roberts, J.D., Polaner, D.M., Lang, P. and Zapol, W.M. (1992) Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet, 340, 818–9.

    Article  PubMed  CAS  Google Scholar 

  43. Kinsella, J.P., Neish, S.R., Shaffer, E. and Abman, S.H. (1992) Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn. Lancet, 340, 819–20.

    Article  PubMed  CAS  Google Scholar 

  44. Girard, C., Lehot, J.J., Pannetier, J.C. et al (1992) Inhaled nitric oxide after mitral valve replacement in patients with chronic pulmonary artery hypertension. Anesthesiology, 77, 880–3.

    Article  PubMed  CAS  Google Scholar 

  45. Rossaint, R., Falke, K.J., Lopez, F. et al. (1993) Inhaled nitric oxide for the adult respiratory distress syndrome. N. Engl. J. Med., 328, 399–05.

    Article  PubMed  CAS  Google Scholar 

  46. Wessel, D.L., Adatia, I., Thompson, J.E. and Hickey, P.R. (1994) Delivery and monitoring of inhaled nitric oxide in patients with pulmonary hypertension. Crit. Care. Med., 22, 930–8.

    Article  PubMed  CAS  Google Scholar 

  47. Grover, E.R., Smithies, M. and Bihari, D.J. (1993) A dose profile of the physiological effects of inhaled nitric oxide in acute lung injury. Am. Rev. Respir. Dis., 147 A350.

    Google Scholar 

  48. Gerlach, H., Rossaint, R., Pappert, D. et al. (1994) Autoinhalation of nitric oxide after endogenous synthesis in nasopharynx. Lancet, 343, 518–9.

    Article  PubMed  CAS  Google Scholar 

  49. Bauich, D.L. and Drysdale, D.D. (1973) Evaluated Kinetic Data for High Temperature Reactions, Butterworth, London.

    Google Scholar 

  50. Hurford, W.E. and Zapol, W.M. (1994) Nitric oxide inhalation in the intensive care unit. Curr. Opin. Anaesth., 7, 153–60.

    Article  Google Scholar 

  51. Foubert, L. Fleming, B. Latimer, R. et al. (1992) Safety guidelines for use of nitric oxide. Lancet, 339, 1615–6.

    Article  PubMed  CAS  Google Scholar 

  52. Beckman, J.S., Beckman, T.W., Chen, J. et al. (1990) Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl Acad. Sei. USA, 87, 1620–4.

    Article  CAS  Google Scholar 

  53. Hogman, M., Frostell, C., Arnberg, H. and Hedenstierna, G. (1993) Bleeding time prolongation and NO inhalation. Lancet, 341, 1664–5.

    Article  PubMed  CAS  Google Scholar 

  54. Watkins, D.N., Jenkins, I.R., Rankin, J.M. and Clarke, GM. (1993) Inhaled nitric oxide in severe acute respiratory failure — its use in intensive care and description of a delivery system. Anaesth. Intensive Care, 21, 861–75.

    PubMed  CAS  Google Scholar 

  55. Fontijin, A., Sabadell, A.J. and Ronco, R.J. (1970) Homogeneous chemiluminescent measurement of nitric oxide with ozone. Anal. Chem., 42, 575–9.

    Article  Google Scholar 

  56. Petros, A. Cox, P. and Bohn, D. (1994) A simple method for monitoring the concentration of inhaled nitric oxide. Anaesthesia, 49, 317–9.

    Article  PubMed  CAS  Google Scholar 

  57. Bihari, D.J. (1987) Indomethacin and arterial oxygenation in critically ill patients with severe bacterial pneumonia. Lancet, 1, 755.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. E. Robert Grover
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David Bihari
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. National Heart & Lung Institute, USA

    Timothy W. Evans MD, FRCP, PhD (Reader in Critical Care Medicine, Consultant in Thoracic and Intensive Care Medicine) (Reader in Critical Care Medicine, Consultant in Thoracic and Intensive Care Medicine)

  2. Royal Brompton Hospital, Sydney Street, London, SW3 6NP, UK

    Timothy W. Evans MD, FRCP, PhD (Reader in Critical Care Medicine, Consultant in Thoracic and Intensive Care Medicine) (Reader in Critical Care Medicine, Consultant in Thoracic and Intensive Care Medicine)

  3. University of Edinburgh, Royal Infirmary, Lauriston Place, Edinburgh, EH3 9YW, UK

    Christopher Haslett FRCP, FRCP (Edin) (Professor of Respiratory Medicine, Chairman of the Department of Medicine (RIE) and Director of the Rayne Laboratories) (Professor of Respiratory Medicine, Chairman of the Department of Medicine (RIE) and Director of the Rayne Laboratories)

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Grover, E.R., Bihari, D. (1996). Inhaled Nitric Oxide Therapy. In: Evans, T.W., Haslett, C. (eds) ARDS Acute Respiratory Distress in Adults. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-3430-7_29

Download citation

  • DOI: https://doi.org/10.1007/978-1-4899-3430-7_29

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-412-56910-4

  • Online ISBN: 978-1-4899-3430-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation